Literature DB >> 18804558

Cloning, bacterial expression, and unique structure of adenosylhomocysteine hydrolase-like protein 1, or inositol 1,4,5-triphosphate receptor-binding protein from mouse kidney.

Tomoharu Gomi1, Fusao Takusagawa, Mikio Nishizawa, Bukhari Agussalim, Isao Usui, Eiji Sugiyama, Hirofumi Taki, Kouichiro Shinoda, Hiroyuki Hounoki, Toshiro Miwa, Kazuyuki Tobe, Masashi Kobayashi, Tetsuya Ishimoto, Hirofumi Ogawa, Hisashi Mori.   

Abstract

Adenosylhomocysteine hydrolase (SAHase)-like protein 1 (SAH-L), also called inositol 1,4,5-triphosphate receptor-binding protein (IRBIT) is a novel protein involved in fish embryo development and calcium release in mammalian cells through protein-protein interactions. To better understand its reaction mechanism, purified protein is indispensable. Here we describe a simple purification procedure and the unique properties of SAH-L. The cDNA was isolated from mouse kidney by RT-PCR and inserted into various pETtrade mark vectors. Escherichia coli harboring a plasmid coding for SAH-L with a C-terminal His-tag could solely produce a soluble protein. SAH-L purified through a Ni(2+) column gave M(r)s of 59,000 and 190,000 by SDS-PAGE and gel filtration, respectively, which is suggestive of a trimer, but chemical cross-linking experiments demonstrated a dimer. The incompatible M(r) values implicate an irregular structure of SAH-L. In fact, SAH-L was partially purified in a form lacking the 31 N-terminal residues, and was found to be extremely susceptible to proteases in the region around residue 70. The N-terminal polypeptide (residues 1-98) was also expressed as a soluble form and was trypsin-sensitive. Circular dichroism revealed a low alpha-helix content but not a randomly extended structure. Interestingly, SAH-L contained tightly bound NAD(+) despite showing no SAHase activity. The characterized properties of SAH-L and its N-terminal fragment present the notion that the structure of the protease-sensitive N-terminal region is relatively loose and flexible rather than compact, and which protrudes from the major SAHase-like domain. This structure is supposed to be favorable to interact with the IP(3) receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804558     DOI: 10.1016/j.bbapap.2008.08.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation.

Authors:  Veerle Vanderheyden; Benoit Devogelaere; Ludwig Missiaen; Humbert De Smedt; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2008-12-16

2.  Splicing variation of Long-IRBIT determines the target selectivity of IRBIT family proteins.

Authors:  Katsuhiro Kawaai; Hideaki Ando; Nobuhiko Satoh; Hideomi Yamada; Naoko Ogawa; Matsumi Hirose; Akihiro Mizutani; Benjamin Bonneau; George Seki; Katsuhiko Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

3.  S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal hydrops and fatal outcomes.

Authors:  Randall Grubbs; Oliver Vugrek; Jeremy Deisch; Conrad Wagner; Sally Stabler; Robert Allen; Ivo Barić; Marko Rados; S Harvey Mudd
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

4.  AHCYL1 is mediated by estrogen-induced ERK1/2 MAPK cell signaling and microRNA regulation to effect functional aspects of the avian oviduct.

Authors:  Wooyoung Jeong; Jinyoung Kim; Suzie E Ahn; Sang In Lee; Fuller W Bazer; Jae Yong Han; Gwonhwa Song
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  IRBIT Interacts with the Catalytic Core of Phosphatidylinositol Phosphate Kinase Type Iα and IIα through Conserved Catalytic Aspartate Residues.

Authors:  Hideaki Ando; Matsumi Hirose; Laura Gainche; Katsuhiro Kawaai; Benjamin Bonneau; Takeshi Ijuin; Toshiki Itoh; Tadaomi Takenawa; Katsuhiko Mikoshiba
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.